What to expect from magic truffles: effects, variability and cautions

You've bought a pouch of magic truffles, or you're thinking about it, and the question that keeps coming back is: what actually happens once you eat them? Search results tend to offer two extremes, a glossy promise and a horror story. The truthful picture sits in between, and it starts with a slightly inconvenient fact. The same pack can produce quite different experiences in different people, or in the same person on a different evening.

This guide pulls together what Dutch harm-reduction services and published research describe: roughly how long things take, what people report, why experiences vary so much, what a difficult experience can look like, and who should skip truffles altogether. It isn't a dosing plan, and it can't predict how your evening will go. Nobody can.

Five things worth knowing first

• Timing: Trimbos-run DRUGSinfo says effects begin 20 to 60 minutes after taking mushrooms or truffles and last about 3 to 4 hours, with people still impaired afterwards (DRUGSinfo, checked 8 October 2026). UK service Talk to FRANK says mushrooms can take more than 30 minutes to work and effects can last up to five hours (Talk to FRANK).
• Variability is the rule. Dose matters most, but a pooled analysis of controlled studies found mood, personality and setting also shaped how pleasant or anxious the response was (Studerus et al., 2012).
• Difficult moments are part of the picture, not a rare glitch. They are usually temporary, but they can be frightening.
• Some people should avoid truffles: anyone with a personal or family history of psychosis, and people on certain medicines, among others (details below).
• Don't drive. Jellinek calls taking part in traffic afterwards "a bad plan and prohibited" (our translation), and DRUGSinfo says you can't yet drive safely once the main effects fade.

What are you actually taking?

Magic truffles are the underground storage structures (sclerotia) of certain Psilocybe fungi. They contain psilocybin, which the body converts to psilocin, the compound that acts on serotonin receptors. A 2025 systematic review of human pharmacokinetic data describes psilocybin as a pro-drug that is rapidly absorbed and converted to psilocin after oral dosing, with a terminal half-life for psilocin of roughly 1.2 to 4.7 hours across studies (Otto et al., 2025, Clinical Pharmacokinetics). That's the chemistry behind the "a few hours" timeline. It describes an average pattern, not a stopwatch for your evening.

The legal bit, as read on 8 October 2026: Jellinek and DRUGSinfo describe fresh truffles as sold legally in Dutch smartshops and mushrooms as banned. Sources differ on dried truffles. Jellinek says they fall under List I of the Opium Act (Jellinek), while DRUGSinfo and Drugs en Uitgaan make no such distinction, so we leave that question open. Dutch rules don't apply elsewhere in the EU, and law changes, so check current rules before relying on any of this.

A rough timeline

Services describe the following pattern. Treat it as a sketch, because individual experiences differ.

• Phase: Before effects; What services and studies describe: Nothing much, or mild nausea, yawning, restlessness; Worth knowing: Onset is quoted at 20 to 60 minutes (DRUGSinfo); Talk to FRANK says more than 30 minutes. Waiting is part of the experience, and the delay is one reason people misjudge how much they've taken.
• Phase: Come-up and peak; What services and studies describe: Colours, sounds and shapes feel more intense; thoughts speed up; time feels distorted; emotions can swing between positive and negative; Worth knowing: DRUGSinfo describes effects arriving in waves. Strength and character differ between people.
• Phase: Coming down; What services and studies describe: Effects fade; people may feel tired, reflective or still a little "off"; Worth knowing: Information services say you can stay blurry and unfocused for some time after the main effects.
• Phase: Next day and after; What services and studies describe: Jellinek advises taking the day after off and planning nothing; some people report feeling well afterwards; Worth knowing: See "After-effects" below; good feelings are reported in surveys, not guaranteed.

Physical effects DRUGSinfo lists include muscle relaxation, chills, headache, nausea or stomach discomfort, dilated pupils, sweating, dizziness, and raised heart rate and blood pressure. Its risk page calls a "body load" (heaviness, nausea, dizziness, chills) nearly universal (DRUGSinfo risks).

Same pack, different evening: why experiences vary

This is the part packaging can't promise away, and it comes from two directions: the truffles and the person.

The truffles aren't uniform. A 2013 analysis of Psilocybe sclerotia sold as "magic truffles" found psilocybin content ranging from 59.3 to 167.8 micrograms per 100 mg of fresh sclerotia (Pellegrini et al., 2013, Drug Testing and Analysis). That is close to a threefold spread between the samples tested. It doesn't tell us how any particular pack behaves today, and a supplier's printed amount is an average claim, not a guarantee. DRUGSinfo says the same in plainer words: there can be a big difference in how strong these products are.

You aren't uniform either. A pooled analysis covered 23 controlled studies, 409 psilocybin administrations and 261 healthy volunteers. Dose was the most important predictor of the response, but personality, mental state beforehand and setting also made a measurable difference. High absorption (a tendency to be deeply drawn into experiences), being emotionally excitable and active beforehand, and having had few recent psychological problems were linked with more pleasant and mystical-type experiences. High emotional excitability and younger age were linked with unpleasant or anxious reactions (Studerus et al., 2012, PLoS ONE). These were laboratory volunteers, so the results only partly map onto a truffle evening at home.

Set and setting is more than a slogan. "Set" is your mindset and "setting" is the environment. A prospective survey of people who planned to take a psychedelic on their own initiative (654 at the first time point, fewer later) found that a positive set, and recreational intentions, were associated with a lower chance of a challenging experience (Haijen et al., 2018, Frontiers in Pharmacology). It is an observational survey, so it shows associations, not that any preparation will prevent a hard time. DRUGSinfo's practical version: a calm, safe place, and a sober trip sitter, meaning someone who hasn't used.

So even with identical truffles in the same room, two people, or the same person on a different day, can end up in different places. That's the real limit of any timeline, including the one above.

Challenging experiences: what they can look like

This is the part a pouch label won't cover, and the research handles it more calmly than most online stories do.

A study that built the Challenging Experience Questionnaire from internet survey responses about difficult psilocybin experiences identified seven themes: grief, fear, death, insanity, isolation, physical distress and paranoia (Barrett et al., 2016, Journal of Psychopharmacology). So "challenging" can mean anything from physical discomfort to feeling afraid you're losing your mind. The authors note that such reactions are usually benign with proper screening, preparation and support in controlled settings, but remain a safety concern in uncontrolled settings.

DRUGSinfo says a bad trip can't be stopped early. The approach is to change the environment and have trusted, sober support, and it ends as the effects wear off (DRUGSinfo risks). That's one reason to be wary of any product that claims to switch a trip off.

If something feels wrong, or if distress or unusual perceptions continue after the effects should have ended, the Drugs Infolijn (0900-1995, listed by DRUGSinfo, phone, chat and email) offers anonymous advice. If someone is in danger or has a medical emergency, call 112.

After-effects: the afterglow and the less cheerful bits

Some people report feeling well in the days afterwards. In the Haijen survey, psychological well-being was higher two and four weeks after a psychedelic experience than before, and stronger mystical-type experiences predicted bigger increases. The participants chose to take part, were not randomised, and didn't take any particular product, so it isn't a result you can plan around.

The less cheerful side, per DRUGSinfo's risk page: psychological complications can include worsening of existing depression, anxiety or panic; psychosis in people predisposed to it; and, for some, lingering visual disturbances (often called flashbacks, clinically hallucinogen persisting perception disorder). It says persistent symptoms deserve professional advice. A 2008 safety review of human hallucinogen research notes that persisting adverse reactions are rare when research follows careful screening and support, with overwhelming distress during the experience the most likely risk and prolonged psychosis less common (Johnson, Richards and Griffiths, 2008). Research conditions are far more controlled than a living room, so that reassurance travels only so far.

Who should avoid magic truffles

According to the sources above, these are the situations to take seriously:

• A personal or family history of psychosis or other severe psychiatric disorders. Johnson and colleagues list excluding these volunteers as a core safeguard in research, and DRUGSinfo says people with mental-health conditions such as depression, anxiety or psychosis face a much greater chance of the risks.
• Anyone using psychiatric or other medicines. DRUGSinfo's risk page says the physical risks are small for healthy people "who don't use medication", and warns that ceremonies are dangerous for people on medicines. It doesn't list specific interactions, so ask a doctor or pharmacist. One published analysis of online experience reports (Nayak et al., 2021, Pharmacopsychiatry) associated combining lithium with classic psychedelics with seizures; that's a report-based association, not a full risk estimate. For the general logic of checking supplements and medicines together, see our guide to supplement and drug interactions.
• Mixing with alcohol or other drugs. DRUGSinfo's risk page frames physical risks as minimal only for healthy people not taking medication or combining substances.
• Anyone who needs to drive, work with machinery or look after others. Jellinek and DRUGSinfo warn that you stay unfocused for some time after, and Jellinek says taking part in traffic is prohibited.
• Anyone who feels pushed. If you're nervous, in a rough patch or in a chaotic place, that matters, because set and setting do.

Is being alone a problem?

DRUGSinfo's guidance is to arrange a trip sitter, "someone who hasn't used". That fits what the research describes: overwhelming distress is the most likely problem, and calm company in a safe place is the usual safeguard. It's a harm-reduction suggestion, not a law, and no one can promise it prevents a hard time.

What the evidence covers

The pharmacology described here is averages and ranges across studies, and the studies mostly use pure psilocybin in clinics, not truffles at home. The evidence on truffles themselves is thin: one lab analysis of sclerotia content, a few harm-reduction pages and a handful of research papers on psilocybin generally. That's why this page can't tell you how strong your truffles are, how you will react or what amount is right for you.

Next reading

If you want to read a label before buying anything supplement-shaped, start with How to read supplement labels.

Written by Smart Supplements with AI assistance from the sources linked in the text. It has not been reviewed by a clinician.

Last updated: 12 October 2026

This article is for informational purposes only and is not intended as medical advice. Always consult a healthcare professional before starting any new supplement, especially if you take prescription medication.